Name: Esam Hamad Alhamad, M.D.
1983-1986 Riyadh High School, Riyadh, Saudi Arabia
1986-1992 College of Medicine, King Saud University, Riyadh, Saudi Arabia; M.D.
2001-2002 University of Michigan School of Public Health, Ann Arbor, MI Clinical Research Design and Statistical Analysis
1999-2002 Fellowship, Pulmonary and Critical Care Medicine (Clinical & Research);Department of Internal Medicine, University of MichiganAnn Arbor, Michigan
1997-1999 Residency, Internal Medicine Case Western Reserve University -University Hospitals of Cleveland, Ohio
1992-1997 Internship and Residency, Internal MedicineKing Fahad National Guard Hospital and King Saud UniversityRiyadh, Saudi Arabia
2003- Assistant Professor & Consultant Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, College of Medicine King Khalid University Hospital
CERTIFICATION AND LICENSURE
Medical Licensure, state of Ohio 1998
Medical and Board of Pharmacy Licensure, state of Michigan 1999
American Board of Internal Medicine, Certified, 1999
Subspecialty Board in Pulmonary Medicine, ABIM, 2001
Subspecialty Board in Critical Care Medicine, ABIM, 2002
HONORS AND AWARDS
Strathmore’s Who’s Who 2001-2002.
American Medical Association: Physicians’ Recognition Award 1999-2002
Super Employee University of Michigan 2000
MEMBERSHIPS AND OFFICES IN PROFESSIONAL SOCIETIES
2000- American Thoracic Society
2000- American College of Chest Physicians
1998- American College of Physicians
1998- American Medical Association
1998- American Society of Internal Medicine
EXTRAMURAL INVITED PRESENTATIONS
9/9/2000 Speaker, Tri-State Thoracic Society Annual Meeting, Egg Harbor, WI. “ Granulomatous Disease”
2/25/2004 Invited speaker, second annual conference Saudi Thoracic Society, Riyadh, Saudi Arabia “Non Specific Interstitial Pneumonia- NSIP”
5/5/2004 Invited speaker, Asthma Awareness Course, King Fahad National Guard Hospital, Riyadh, Saudi Arabia “Approach to Chronic Cough”
09/03/2005 Speaker, Internal Medicine Update2005, King Saud University “Interstitial Lung Disease”
18/3/2008 Invited speaker, sixth annual scientific conference, Saudi Thoracic Society, Riyadh Saudi Arabia"IPF: Current understanding and management
1. Alhamad EH, Idrees MM , Alanezi MO, AlBoukai AA , Shaikh S. Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients. Accepted for publication. Ann Thorac Med.
2. Alhamad EH. Familial interstitial lung disease in four members of one family: a case series. Cases J. 2009 Dec 19;2:9356
3. Alhamad EH, Alanezi MO, Idrees MM, Chaudhry MK, AlShahrani AM, Isnani A, Shaikh S. Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis. Ann Saudi Med 2009;29:454-9
4. Alhamad EH. The six-minute walk test in patients with pulmonary sarcoidosis. Ann Thorac Med 2009;4:60-4
5. Alhamad EH, Masaood M, Shaik SA, Arafah A. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis. The Clinical Respiratory Journal 2008;2: 220-226
6. Alzeer A, BaHammam A, Masood M, Basha SJ, Alhamad E, Sohail S. Outcome of patients with severe asthma in the intensive care uinit. Ann Saudi Med 2006: 461-465
1. 1. Alhamad EH, Gay SE, Flaherty KR, Martinez FJ. Evaluating chronic dyspnea: A step- wise approach. J Respir Dis 2001; 22: 79-88.
2. Alhamad EH, Lynch JP III, Martinez FJ. Pulmonary function testing in interstitial lung disease: What role do they have?. Clin Chest Med 2001; 22:715-50.
Chapters in Books
1. Alhamad EH, Martinez FJ. Pulmonary disorders during pregnancy. In: Pearlman M, Tintinalli JE, eds. Emergent Care of Woman. New York, NY. Mc-Graw-Hill. 2003, ISBN: 0071379371
Abstracts, Preliminary Communications, Panel Discussions
1. Alhamad EH, Kazerooni E, Flaherty K, Iannettoni M, Gay S, Bria W, Martinez FJ
Survival in COPD is dependent on emphysema volume by helical CT. Am J Respir Crit Care Med 2001; 163: A909
2. Bria W, Alhamad E, Flaherty K, Kazerooni E, Iannettoni M, Gay S, Martinez FJ.
Difference in COPD patients with vs without severe emphysema quantified by helical CT. Am J Respir Crit Care Med 2001; 163: A912
3. Gay S, Flaherty K, Alhamad E, Kazerooni E, Iannettoni M, Bria W, Martinez FJ.
Six minute walk distance (6MWD) in COPD: Role of emphysema volume by helical CT. Am J Respir Crit Care Med 2001; 163: A912
4. Deborah C, Kazerooni EA, Alhamad, EH, Flaherty K, Martinez FJ.
Predictors of survival in patients with emphysema, including severity of emphysema using quantitative helical CT, functional and physiologic parameters. Submitted for the Radiological Society of North America 2001
5. Deborah C, Kazerooni EA, Alhamad, EH, Flaherty K, Martinez FJ.
Smoking History and emphysema severity at quantitative helical CT. Submitted for the Radiological Society of North America 2001
6. Alhamad E, Bach D, Kazerooni E, Flaherty K, Gay S, Ojo T, Martinez FJ.
Survival is worse in COPD patients with Right Heart Abnormalities on Echocardiography (ECHO). Am J Respir Crit Care Med 2002; 165: A445.
7. Gay S, Alhamad E, Bach D, Kazerooni E, Flaherty K, Ojo T, Martinez FJ.
Survival in COPD patients < 65 years of age is dependent on emphysema volume by HRCT. Am J Respir Crit Care Med 2002; 165: A656.